LobbyingMCS Advantage lobbying by quarter
MCS Advantage's latest lobbying report covers Q2 2026, at $50K. The four quarters Q4 2025–Q3 2026 total $150K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid.
MCS Advantage
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $150K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $50K | 1 |
| Q1 2023 | $50K | 1 |
| Q2 2023 | $50K | 1 |
| Q3 2023 | $50K | 1 |
| Q4 2023 | $50K | 1 |
| Q1 2024 | $50K | 1 |
| Q2 2024 | $50K | 1 |
| Q3 2024 | $50K | 1 |
| Q4 2024 | $50K | 1 |
| Q1 2025 | $50K | 1 |
| Q2 2025 | $50K | 1 |
| Q3 2025 | $50K | 1 |
| Q4 2025 | $50K | 1 |
| Q1 2026 | $50K | 1 |
| Q2 2026 | $50K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$750K · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Centers For Medicare and Medicaid Services (CMS)14 reports
- Health & Human Services, Dept of (HHS)14 reports
Firms it paid
| Firm | ||
|---|---|---|
| King & Spalding | $750K | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | King & Spalding | $50K |
| 04/18for Q1 | King & Spalding | $50K |
| 01/19for Q4 2025 | King & Spalding | $50K |
| 25/10/20for Q3 2025 | King & Spalding | $50K |
| 25/07/21for Q2 2025 | King & Spalding | $50K |
| 25/04/18for Q1 2025 | King & Spalding | $50K |
| 25/01/13for Q4 2024 | King & Spalding | $50K |
| 24/10/18for Q3 2024 | King & Spalding | $50K |
| 24/07/22for Q2 2024 | King & Spalding | $50K |
| 24/04/19for Q1 2024 | King & Spalding | $50K |
| 24/01/16for Q4 2023 | King & Spalding | $50K |
| 23/10/18for Q3 2023 | King & Spalding | $50K |
| 23/07/11for Q2 2023 | King & Spalding | $50K |
| 23/04/07for Q1 2023 | King & Spalding | $50K |
| 23/01/18for Q4 2022 | King & Spalding | $50K |